Tipelukast

Tipelukast (KCA 757 or MN-001) is a sulfidopeptide leukotriene receptor antagonist with suspected anti-inflammatory properties. It is developed by MediciNova.
Wikipedia contributors, "Tipelukast", Wikipedia, revision 1330634590, retrieved 20 November 2026, source, CC BY-SA 4.0.